Review of Therapeutic Modalities Acting Directly Via Central Pathways

References

• Adler-Graschinsky E, Langer SZ. Possible role of β-adrenoceptor in the regulation of noradrenaline release by nerve stimulation through a positive feed-back mechanism. Br J Pharmacol 1975; 53: 43
   PubMed Web of Science ®Google Scholar
• Arbilla S, Langer SZ. Differences between the presynaptic and postsynaptic alpha-adrenoceptors in cat nictitating membrane: effects of metanephrine and tolazoline. Br J Pharmacol 1978; 64: 259
   PubMed Web of Science ®Google Scholar
• Baer L, Brunner HR, Bard R, Laragh JH. Suppression of renin and aldosterone by clonidine. Ann Intern Med 1971; 74: 830
   Web of Science ®Google Scholar
• Berthelsen S, Pettinger WA. A functional basis for classification of α-adrenergic receptors. Life Sci 1977; 21: 595
   PubMed Web of Science ®Google Scholar
• Brest AN. Hemodynamic and cardiac effects of clonidine. J Cardiovasc Pharmacol 1980; 2: S39
   PubMed Web of Science ®Google Scholar
• Brod J, Horbach L, Just H, Rosenthal J, Nicolescu R. Acute effects of clonidine on central and peripheral hemodynamics and plasma renin activity. Eur J Clin Pharmacol 1972; 4: 107
   PubMed Web of Science ®Google Scholar
• Day MD, Roach AG. Cardiovascular effects of beta-adrenoceptor blocking agents intracerebroventricular administration in conscious normotensive cats. Clin Exp Pharmacol Physiol 1974; 1: 333
   PubMed Web of Science ®Google Scholar
• Dubocovich ML, Langer SZ. Dopamine and alpha-adrenoceptor agonists inhibit neurotransmission in the cat spleen through different presynaptic receptors. J Pharmac Exp Ther 1980; 212: 144
   PubMed Web of Science ®Google Scholar
• Fuxe K, Jonsson G, Bolme P, Andersson K, Agnati LF, Goldstein M, Hokfelt T. Reduction of adrenaline turnover in cardiovascular areas of rat medulla oblongata by clonidine. Acta Physiol Scand 1979; 107: 117
   Google Scholar
• Ganong WF. The renin angiotensin system and the central nervous system. Fed Proc 1977; 36: 1771
   PubMedGoogle Scholar
• Goldberg LI, Rick JH, Oparil S. Pharmacology of antihypertensive agents. Hypertension, J. Genest, E. Koiw, O. Kuchel. McGraw-Hill, New York 1977; 990
   Google Scholar
• Guimaraes S, Brandao F, Paiva MQ. A study of the adrenoceptor-mediated feedback mechanisms by using adrenaline as a false transmitter. Naunyn-Schmiedebergs Arch Pharmacol 1978; 305: 185
   PubMed Web of Science ®Google Scholar
• Haeusler G, Finch L. On the nature of the central hypotensive effect of clonidine and α-methyldopa. J Pharmacol 1972; 3: 554
   Google Scholar
• Haeusler G. Clonidine induced inhibition of sympathetic nerve activity: No indication for a central presynaptic or an indirect sympathomimetic mode of action. Naunyn-Schmiedebergs' Arch Pharmacol 1974; 286: 97
   Web of Science ®Google Scholar
• Henning M. Studies on the mode of action of α-methyldopa. Acta Physiol Scand 1969; 322: 1
   Google Scholar
• Hess SM, Connamacher RH. The effects of alpha-methyldopa and alpha-methyl-meta-tyrosine on the metabolism of norepinephrine and serotonin in vivo. J Pharmacol Exp Ther 1961; 134: 129
   PubMed Web of Science ®Google Scholar
• Hokfelt B, Hedeland H, Hansson BG. The effect of clonidine and penbutolol, respectively on catecholamines in blood and urine, plasma renin activity and urinary aldosterone in hypertensive patients. Arch Int Pharmacodyn Ther 1975; 213: 307
   PubMedGoogle Scholar
• Hunyor SN, Hansson L, Harrison TS, Hoobler SW. Effects of clonidine withdrawal: Possible mechanisms and suggestions for management. Br Med J 1973; 2: 209
   PubMed Web of Science ®Google Scholar
• Langer SZ. Presynaptic regulation of catecholamine release. Biochem Pharmacol 1974; 23: 1793
   PubMed Web of Science ®Google Scholar
• Langer SZ. Presynaptic receptors and their role in the regulation of transmitter release. Br J Pharmacol 1977; 60: 481
   PubMed Web of Science ®Google Scholar
• Langer SZ. Presynaptic adrenoceptors and regulation of release. The Release of Catecholamines from Adrenergic Neurons, DM Paton. Pergamon Press, New York 1979
   Google Scholar
• Langer SZ, Cavero I, Massinham R. Recent developments in noradrenergic neurotransmission and its relevance to the mechanism of action of certain antihypertensive agents. Hypertension 1980; 2: 372
   PubMed Web of Science ®Google Scholar
• Lewis PJ, Haeusler G. Reduction in sympathetic nervous activity as a mechanism of the hypotensive effect of propranolol. Nature (Lond) 1975; 256: 440
   PubMed Web of Science ®Google Scholar
• Lund-Johansen P. Hemodynamic changes at rest and during exercise in long-term clonidine therapy of essential hypertension. Acta Med Scand 1974; 195: 111
   PubMed Web of Science ®Google Scholar
• Mancia G, Ferrari A, Gregorini L, Bianchini C, Terzoli L, Leonetti G, Zanchetti A. Methyldopa and neural control of circulation in essential hypertension. Am J Cardiol 1980; 45: 1237
   PubMed Web of Science ®Google Scholar
• McRaven DR, Kroetz FW, Kioschos JM, Kirkendall WM. The effect of clonidine on hemodynamics in hypertensive patients. Am Heart J. 1971; 81: 482
   PubMed Web of Science ®Google Scholar
• Myers MG, Lewis PJ, Reid JL, Dollery CT. Brain concentration of propranolol in relation to hypotensive effect in the rabbit with observations on brain propranolol levels in man. J Pharmacol Exp Ther 1975; 192: 327
   PubMed Web of Science ®Google Scholar
• Onesti G, Bock KD, Heimsoth V, Kim KE, Merguet P. Clonidine a new antihypertensive agent. Am J Cardiol 1971; 28: 74
   PubMed Web of Science ®Google Scholar
• Onesti G, Kim KE, Swartz C, Moyer JH. Hemodynamic effects of antihypertensive agents. Hypertension, Mechanisms and Management, G. Onesti, KE Kim, JH Moyer. Grune and Stratton, New York 1973; 227
   Google Scholar
• Onesti G, Schwartz AB, Kim KE, Swartz C, Brest AN. Pharmacodynamic effects of a new antihypertensive drug, Catapres (ST 155). Circulation 1969; 39: 219
   PubMed Web of Science ®Google Scholar
• Onesti G, Schwartz AM, Kim KE, Paz-Martinez V, Swartz C. Antihypertensive effect of clonidine. Circ Res (Suppl II) 1971; 28: 53
   PubMedGoogle Scholar
• Olson UB. Clonidine-induced increase of renal prostaglandin activity and water diuresis in conscious dogs. Eur J Pharmacol 1976; 36: 95
   PubMed Web of Science ®Google Scholar
• Pettinger WA, Keeton TK, Campbell WB, Harper DC. Evidence for a renal adrenergic receptor inhibiting renin release. Circ Res 1976; 38: 338
   PubMed Web of Science ®Google Scholar
• Prichard B NC, Gillam P MS. Treatment of hypertension with propranolol. Br Med J 1969; 1: 7
   PubMed Web of Science ®Google Scholar
• Reid IA, MacDonald DM, Pachnis B, Ganong WF. Studies concerning the mechanism of suppression of renin secretion by clonidine. J Pharmacol Exp Ther 1975; 192: 713
   PubMed Web of Science ®Google Scholar
• Reid JL, Dargie HJ, Davies DS, Wing L MH, Hamilton CA, Dollery CT. Clonidine withdrawal in hypertension. Lancet 1977; 1: 1171
   PubMed Web of Science ®Google Scholar
• Reid JL, Lewis PJ, Myers MG, Dollery CT. Cardiovascular effects of intracerebroventricular d-, 1- and dl-propranolol in conscious rabbit. J Pharmacol Exp Ther 1974; 188: 394
   PubMed Web of Science ®Google Scholar
• Sannerstedt R, Bojs G, Varnauskas E, Werko L. Alpha-methyldopa in arterial hypertension. Clinical, renal and hemodynamic studies. Acta Med Scand 1963; 174: 53
   PubMed Web of Science ®Google Scholar
• Sannerstedt R, Conway J. Hemodynamic and vascular responses to antihypertensive treatment with adrenergic blocking agents: a review. Am Heart J 1970; 70: 122
   Google Scholar
• Schmitt H. The pharmacology of clonidine and related products. Antihypertensive Agents, F. Gross. Springer-Verlag, Berlin, Heidelberg, New York 1977; 299–396
   Google Scholar
• Sjoerdsma A, Vendsalu A, Engleman K. Studies on the metabolism and mechanism of action of methyldopa. Circulation 1963; 28: 492
   PubMed Web of Science ®Google Scholar
• Starke K, Endo T. Presynaptic α-adrenoceptors. Gen Pharmacol 1976; 7: 307
   PubMedGoogle Scholar
• U'Prichard DC, Bechtel WD, Rovot BM, Snyder SH. Multiple apparent alpha-noradrenergic receptor binding sites in rat brain: Effect of 6-hydroxydopamine. Mol Pharmacol 1979; 16: 47
   PubMed Web of Science ®Google Scholar
• Warnke E, Hoefke W. Influence of central pretreatment with 6-hydroxydopamine on the hypotensive effect of clonidine. Arzneimittel-Forsch 1977; 27: 2311
   PubMed Web of Science ®Google Scholar
• Weber MA. Discontinuation syndrome following cessation of treatment with clonidine and other antihypertensive agents. J Cardiovasc Pharmacol 1980; 2: S73
   PubMed Web of Science ®Google Scholar
• Weber MA, Case DB, Baer L, Sealey JE, Drayer J IM, Lopez-Ovejero JA, Laragh JH. Renin and aldosterone suppression in the antihypertensive action of clonidine. Am J Cardiol 1976; 38: 825
   PubMed Web of Science ®Google Scholar
• Weinshilboum RM. Antihypertensive drugs that alter adrenergic function. Mayo Clin Proc 1980; 55: 390
   PubMed Web of Science ®Google Scholar
• Westfall TC, Peach MJ, Tittermary V. Enhancement of the electrically induced release of norepinephrine from the rat portal vein: medication by β2-adrenoceptors. Eur J Pharmacol 1979; 58: 67
   PubMed Web of Science ®Google Scholar
• Wikberg J ES. The pharmacological classification of adrenergic α1 and α2 receptors and their mechanisms of action. Acta Physiol Scand 1979; 1, Suppl 468
   Google Scholar
• Wilkins LH, Winternitz SR, Oparil S, Smith LR, Dustan HP. Lofexidine and clonidine in moderate essential hypertension. Clin Pharmacol Ther., In press
   Web of Science ®Google Scholar
• Wood CL, Arnett CD, Clarke WE, Tsai BS, Lefkowitz RJ. Subclassification of alpha adrenergic receptors by direct binding studies. Biochem Pharmacol 1979; 28: 1277
   PubMed Web of Science ®Google Scholar